IOL CHEMICALS & PHARM. | LUPIN | IOL CHEMICALS & PHARM./ LUPIN |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 39.0 | 33.8% | View Chart |
P/BV | x | 1.5 | 5.7 | 26.2% | View Chart |
Dividend Yield | % | 1.0 | 0.3 | 402.2% |
IOL CHEMICALS & PHARM. LUPIN |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
LUPIN Mar-23 |
IOL CHEMICALS & PHARM./ LUPIN |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 799 | 67.2% | |
Low | Rs | 272 | 583 | 46.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 365.8 | 103.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 9.8 | 240.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 29.2 | 108.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 4.00 | 100.0% | |
Avg Dividend yield | % | 1.0 | 0.6 | 170.8% | |
Book value per share (Unadj.) | Rs | 256.8 | 270.7 | 94.9% | |
Shares outstanding (eoy) | m | 58.71 | 454.98 | 12.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.9 | 56.7% | |
Avg P/E ratio | x | 17.1 | 70.2 | 24.3% | |
P/CF ratio (eoy) | x | 12.8 | 23.7 | 54.1% | |
Price / Book Value ratio | x | 1.6 | 2.6 | 61.7% | |
Dividend payout | % | 16.9 | 40.7 | 41.5% | |
Avg Mkt Cap | Rs m | 23,743 | 314,381 | 7.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 30,872 | 5.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 166,417 | 13.3% | |
Other income | Rs m | 256 | 1,509 | 17.0% | |
Total revenues | Rs m | 22,427 | 167,926 | 13.4% | |
Gross profit | Rs m | 2,257 | 17,206 | 13.1% | |
Depreciation | Rs m | 462 | 8,807 | 5.2% | |
Interest | Rs m | 165 | 2,743 | 6.0% | |
Profit before tax | Rs m | 1,887 | 7,165 | 26.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 2,688 | 18.4% | |
Profit after tax | Rs m | 1,391 | 4,477 | 31.1% | |
Gross profit margin | % | 10.2 | 10.3 | 98.4% | |
Effective tax rate | % | 26.2 | 37.5 | 70.0% | |
Net profit margin | % | 6.3 | 2.7 | 233.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 124,513 | 7.8% | |
Current liabilities | Rs m | 5,025 | 92,654 | 5.4% | |
Net working cap to sales | % | 20.9 | 19.1 | 109.3% | |
Current ratio | x | 1.9 | 1.3 | 143.1% | |
Inventory Days | Days | 43 | 26 | 165.0% | |
Debtors Days | Days | 8 | 98 | 8.5% | |
Net fixed assets | Rs m | 11,017 | 103,490 | 10.6% | |
Share capital | Rs m | 587 | 910 | 64.5% | |
"Free" reserves | Rs m | 14,490 | 122,246 | 11.9% | |
Net worth | Rs m | 15,077 | 123,156 | 12.2% | |
Long term debt | Rs m | 0 | 275 | 0.0% | |
Total assets | Rs m | 20,684 | 228,003 | 9.1% | |
Interest coverage | x | 12.5 | 3.6 | 344.8% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.7 | 146.9% | |
Return on assets | % | 7.5 | 3.2 | 237.6% | |
Return on equity | % | 9.2 | 3.6 | 253.9% | |
Return on capital | % | 13.6 | 8.0 | 169.5% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 48,057 | 12.3% | |
Fx outflow | Rs m | 6,052 | 21,752 | 27.8% | |
Net fx | Rs m | -122 | 26,306 | -0.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 18,972 | 6.4% | |
From Investments | Rs m | -1,200 | -12,868 | 9.3% | |
From Financial Activity | Rs m | -41 | -3,373 | 1.2% | |
Net Cashflow | Rs m | -18 | 2,732 | -0.7% |
Indian Promoters | % | 48.2 | 46.7 | 103.1% | |
Foreign collaborators | % | 0.0 | 0.3 | - | |
Indian inst/Mut Fund | % | 1.7 | 46.1 | 3.7% | |
FIIs | % | 1.4 | 18.3 | 7.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 53.0 | 97.8% | |
Shareholders | 130,003 | 280,248 | 46.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Lupin | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | -2.92% | -0.44% |
1-Month | -4.51% | -1.41% | 2.15% |
1-Year | -4.09% | 125.24% | 49.82% |
3-Year CAGR | -12.01% | 13.38% | 14.21% |
5-Year CAGR | 15.35% | 13.22% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Lupin share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Lupin the stake stands at 47.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Lupin.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Lupin.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.